Literature DB >> 23292925

Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child.

Helen Dimaras1, Manoj Vijay Parulekar, Grace Kwok, E Rand Simpson, Asim Ali, William Halliday, Mary Shago, J William Harbour, Elise Héon, Brenda L Gallie, Helen S L Chan.   

Abstract

AIMS: To characterise a histologically unusual paediatric uveal melanoma by gene expression and karyotypic profiling and assess prognosis.
METHODS: The tumour was studied by histopathology, karyotype analysis, single nucleotide polymorphism and gene expression profile analysis for correlation with clinical outcome.
RESULTS: The tumour had predominantly epithelioid histology. Karyotype analysis showed none of the poor prognosis features normally associated with uveal melanoma. single nucleotide polymorphism analysis revealed no imbalance at chromosome 3. Gene expression profiling indicated low risk disease.
CONCLUSIONS: We report a child remaining relapse-free 6 years after diagnosis of a very rare uveal melanoma, with poor prognosis epithelioid histology, but gene expression profiling that accurately predicted low risk disease.

Entities:  

Mesh:

Year:  2013        PMID: 23292925      PMCID: PMC4966167          DOI: 10.1136/bjophthalmol-2012-302561

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.

Authors:  Carol L Shields; Swathi Kaliki; Minoru Furuta; Arman Mashayekhi; Jerry A Shields
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

2.  Iris melanoma: features and prognosis in 317 children and adults.

Authors:  Carol L Shields; Swathi Kaliki; Sanket U Shah; Wenjuan Luo; Minoru Furuta; Jerry A Shields
Journal:  J AAPOS       Date:  2012-02       Impact factor: 1.220

3.  Ossification in choroidal melanoma.

Authors:  T K Chan; H R Atta; G B Scott
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

4.  Uveal melanoma in a 19-month-old child.

Authors:  Anna Grabowska; José Abelarias; Jesús Peralta; Mónica Asencio; Miguel Ángel García-Cabezas; Cristina Escabias-Del Pozo; Julian Nevado; Elena Vallespin; Jesús Solera; Pilar Martínez Pilar; Ana Sastre-Urgellés
Journal:  J AAPOS       Date:  2011-12       Impact factor: 1.220

Review 5.  Uveal melanoma: natural history and treatment options for metastatic disease.

Authors:  E Wöll; A Bedikian; S S Legha
Journal:  Melanoma Res       Date:  1999-12       Impact factor: 3.599

6.  Iris mammillations as the only sign of ocular melanocytosis in a child with choroidal melanoma.

Authors:  K Gündüz; C L Shields; J A Shields; R C Eagle; A D Singh
Journal:  Arch Ophthalmol       Date:  2000-05

7.  Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.

Authors:  Andrea G M Scholes; Bertil E Damato; Janice Nunn; Paul Hiscott; Ian Grierson; John K Field
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

8.  Cytogenetics of uveal melanoma: a 7-year clinical experience.

Authors:  Bertil Damato; Catherine Duke; Sarah E Coupland; Paul Hiscott; Peter A Smith; Ian Campbell; Angela Douglas; Peter Howard
Journal:  Ophthalmology       Date:  2007-08-27       Impact factor: 12.079

9.  Choroidal melanoma in a 14-year-old patient with ocular melanocytosis.

Authors:  K Gündüz; J A Shields; C L Shields; R C Eagle
Journal:  Arch Ophthalmol       Date:  1998-08

10.  Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma.

Authors:  V A White; J D Chambers; P D Courtright; W Y Chang; D E Horsman
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.